Top Stories

Career Development: Being Comfortable With Being Uncomfortable

By Joseph Mullings We are working with a great client in the Silicon Valley area, building out an amazing technology that revolves around a surgical robotic platform.  We have been moving individuals out to Silicon Valley at an amazing rate as they choose to pursue [...]

Selling your soul

By Joseph Mullings I was chatting the other day with an individual who was considering accepting one of three offers that he had in front of him. He was a recent graduate out of university, had a newly minted PhD and said to me “that [...]

Boston and Bay Area: Promise in Med-Tech

By Joseph Mullings The Med-tech space, especially in Boston and the Bay Area, continue to be on a very nice growth trajectory. Ongoing collaborations between med-tech companies and non med-tech companies who are entering into the space as partners is promising. In the last six months, our firm has [...]

International News

Cardiac Dimensions® Initiates European Commercialization of CARILLON® Mitral Contour System®

Commercial Rollout includes PRIME Study, Collecting Data on up to 300 European Patients KIRKLAND, Wash., Sept. 28, 2012 — /PRNewswire/ --Cardiac Dimensions®,Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its [...]

$265 million for Israeli-founded medical device company

An admirable exit for the Israeli-founded medical device company, Rhythmia Medical, as it gets picked up by Boston Scientific – a worldwide developer, manufacturer and marketer of medical devices- for $265 million. The agreement (signed today) calls for an upfront payment of $90 million payable [...]

Implant scandal sparks revamp of EU medical device rules

*Rules to tighten product approvals, safety checks * Changes follow French breast implant safety scandal * Plans must be approved by EU governments, lawmakers BRUSSELS, Sept 26 (Reuters) - The European Union has proposed tougher rules on assessing the safety and monitoring the use of [...]

European regulators approve Surefire Infusion System for chemo – and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately. "Surefire Medical developed this ground-breaking technology to provide interventional [...]